Abstract:397 The host defense against viral infection involves the recognition of pathogen-associated molecular patterns by a set of host patternrecognition receptors1–3. Following viral infection, viral RNA in the endosome is recognized by membrane-bound Toll-like receptors (TLRs), and cytoplasmic viral double-stranded RNA is sensed by RNA helicase RIG-I–like receptors (RLRs). In addition, a small number of sensors of viral DNA have been identified, including DAI, IFI16, DDX41, MRE11 and cGAS4. Stimulation of these sensors triggers a series of signaling events to activate the transcription factors NF-κB, IRF3 or IRF7 and leads to the subsequent induction of type I interferons1–4. Insufficient interferon production causes chronic infection, whereas excessive interferon causes autoimmune and/or inflammatory diseases5–7. Therefore, balanced production of interferons is proposed as having a key role in the pathogenesis of autoimmune diseases as well as protective immune responses to viruses5–7. Much progress has been made in characterizing viral nucleic acid–triggered signaling pathways that result in the transcriptional activation of genes encoding type I interferons. After recognition of viral RNA through the RNA helicase domain (RLD), RLRs (including RIG-I and MDA5) interact with the signaling adaptor MAVS (also known as IPS-1, Cardif or VISA)1–3. MAVS further recruits the signaling adaptor TRAF3 and leads to Lys63 (K63)-linked ubiquitination of TRAF3, which subsequently interacts with a complex containing the kinases TBK1 and IKKε to activate the promoter of the gene encoding interferon-β (IFN-β)8–10. The stimulation of TLRs by viral nucleic acids leads to recruitment of the signaling adaptor TRIF (TICAM1) to induce IFN-β expression. The association of TRIF with TRAF3 and TBK1 triggers the activation of multiple intracellular cascades to induce IFN-β expression1. TRAF3 belongs to the TRAF family of ring-finger ubiquitin E3 ligases and is a versatile immunoregulator that undertakes its multiple functions in highly receptorand cell type–dependent manner10,11. Gene-ablation studies have demonstrated that TRAF3 is essential in the virus-triggered induction of IFN-β12,13. Increasing evidence suggests that the ubiquitination and de-ubiquitination of TRAF3 regulate the virus-triggered IFN-β-induction pathways. It has been shown that the tyrosine phosphatase PTPN22 and cellular apoptosis inhibitors cIAP1 and cIAP2 promote K63-linked ubiquitination of TRAF3 and regulate virus-triggered induction of type I interferons14,15. In contrast, the ubiquitin-modifying enzyme DUBA and ubiquitinbinding proteins HSCARG (NMRAL1), OTUB1/2 and UCHL1 have been shown to negatively regulate virus-induced interferon production through inhibiting the K63-linked ubiquitination of TRAF3, which is important for the recruitment of TBK1 (refs. 16–19). In addition, Triad3A, an E3 ubiquitin-protein ligase, negatively regulates the RIG-I RNA-sensing pathway through K48-linked-ubiquitin-mediated degradation of TRAF3 (ref. 20). However, whether and how additional molecules mediate other types of post-translational modifications of TRAF3 is unknown. Members of the CK1 family are evolutionary highly conserved and ubiquitously expressed serine-threonine–specific kinases that comprise six isoforms (CK1α, CK1δ, CK1ε and CK1γ1–CK1γ3) in vertebrates, which are highly conserved within their kinase domains but differ substantially in their amino acid sequence and length of their aminoand carboxy-terminal domains21,22. CK1 kinases

TaSRT2 Recognizes a Viral Protein to Activate Host Immunity by Increasing Histone Acetylation

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Methyltransferase Dnmt3a Upregulates HDAC9 to Deacetylate the Kinase TBK1 for Activation of Antiviral Innate Immunity.

The roles of nuclear orphan receptor NR2F6 in anti-viral innate immunity

The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells

A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses

Down-Regulation Of Mhc Class Ii Expression Through Inhibition Of Ciita Transcription By Lytic Transactivator Zta During Epstein-Barr Virus Reactivation

Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection

A CRISPR Activation Screen Identifies Genes That Enhance SARS-CoV-2 Infection

Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection

SAFA facilitates chromatin opening of immune genes through interacting with anti-viral host RNAs

MITAgating Viral Infection

Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis

NS1-mediated enhancement of MVC transcription and replication promoted by KAT5/H4K12ac

Demalonylation Of Ddx3 By Sirtuin 5 Promotes Antiviral Innate Immune Responses

Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection

The Chromatin Modification by Sumo-2/3 but Not Sumo-1 Prevents the Epigenetic Activation of Key Immune-Related Genes During Kaposi'S Sarcoma Associated Herpesvirus Reactivation

Activation of STAT6 by STING Is Critical for Antiviral Innate Immunity

Spatial proteomics identifies a novel CRTC-dependent viral sensing pathway that stimulates production of Interleukin-11

KAT5 acetylates cGAS to promote innate immune response to DNA virus

The host defense against viral infection involves the recognition of pathogen-associated molecular patterns by a set of host pattern- recognition receptors1–3. Following viral infection, viral RNA in the endosome is recognized by membrane-bound Toll-like recep-